Intrinsic Value of S&P & Nasdaq Contact Us

Penumbra, Inc. PEN NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
67/100
3/7 Pass
SharesGrow Intrinsic Value
$304.88
-8.2%
Analyst Price Target
$371.92
+12%

Stock Statistics — PEN

Penumbra, Inc. (PEN) has a market capitalization of $13.04B and trades at $332.17. The 52-week range is 221.26-362.41.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 72.7, Earnings Per Share (EPS) of $4.57, annual revenue of $1.4B.

The stock has a beta of 0.84, operates in the Healthcare sector.

Trading Data
Current Price$332.17
52-Week Range221.26-362.41
Volume251.1K
Avg Volume (30D)1.02M
Market Cap$13.04B
Beta (1Y)0.84
Company
IPO Date2015-09-18
Employees4,500
CEOAdam Elsesser
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS70975L1070
CUSIP70975L107
Income (Latest Year)
Revenue$1.4B
Gross Profit$942.44M
EBITDA$222.6M
Operating Income$189.25M
Net Income$177.69M
EPS$4.57
EPS Diluted$4.52
Shares Outstanding$38.92M
Balance Sheet (Latest Year)
Total Assets$1.83B
Current Assets$1.22B
Cash & ST Investments$186.9M
Total Liabilities$398.92M
Total Debt$219.7M
Net Debt$32.8M
Total Equity$1.43B
Debt / Equity0.15
Valuation Ratios
P/E Ratio72.7
P/S Ratio9.29
P/B Ratio9.13
EV/EBITDA (approx)58.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message